BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24994928)

  • 21. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors.
    Cox CD; Hostetler ED; Flores BA; Evelhoch JL; Fan H; Gantert L; Holahan M; Eng W; Joshi A; McGaughey G; Meng X; Purcell M; Raheem IT; Riffel K; Yan Y; Renger JJ; Smith SM; Coleman PJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4893-4898. PubMed ID: 26077491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain.
    Tu Z; Fan J; Li S; Jones LA; Cui J; Padakanti PK; Xu J; Zeng D; Shoghi KI; Perlmutter JS; Mach RH
    Bioorg Med Chem; 2011 Mar; 19(5):1666-73. PubMed ID: 21315609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo Characterization of Two
    Liu H; Jin H; Luo Z; Yue X; Zhang X; Flores H; Su Y; Perlmutter JS; Tu Z
    ACS Chem Neurosci; 2018 May; 9(5):1066-1073. PubMed ID: 29400443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of 2-(2-(3-(4-([
    Mori W; Yamasaki T; Fujinaga M; Ogawa M; Zhang Y; Hatori A; Xie L; Kumata K; Wakizaka H; Kurihara Y; Ohkubo T; Nengaki N; Zhang MR
    J Med Chem; 2019 Jan; 62(2):688-698. PubMed ID: 30516998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A.
    Plisson C; Salinas C; Weinzimmer D; Labaree D; Lin SF; Ding YS; Jakobsen S; Smith PW; Eiji K; Carson RE; Gunn RN; Rabiner EA
    Nucl Med Biol; 2011 Aug; 38(6):875-84. PubMed ID: 21843784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer.
    Hu E; Ma J; Biorn C; Lester-Zeiner D; Cho R; Rumfelt S; Kunz RK; Nixey T; Michelsen K; Miller S; Shi J; Wong J; Hill Della Puppa G; Able J; Talreja S; Hwang DR; Hitchcock SA; Porter A; Immke D; Allen JR; Treanor J; Chen H
    J Med Chem; 2012 May; 55(10):4776-87. PubMed ID: 22548439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.
    Takano A; Stepanov V; Gulyás B; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Halldin C
    Synapse; 2015 Jul; 69(7):345-55. PubMed ID: 25892433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of binding and inhibitory properties of TAK-063, a novel phosphodiesterase 10A inhibitor.
    Harada A; Suzuki K; Kamiguchi N; Miyamoto M; Tohyama K; Nakashima K; Taniguchi T; Kimura H
    PLoS One; 2015; 10(3):e0122197. PubMed ID: 25815469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.
    Tu Z; Xu J; Jones LA; Li S; Mach RH
    Nucl Med Biol; 2010 May; 37(4):509-16. PubMed ID: 20447563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [
    Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
    Brain Res; 2019 May; 1711():140-145. PubMed ID: 30664847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging.
    Andrés JI; De Angelis M; Alcázar J; Iturrino L; Langlois X; Dedeurwaerdere S; Lenaerts I; Vanhoof G; Celen S; Bormans G
    J Med Chem; 2011 Aug; 54(16):5820-35. PubMed ID: 21777010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, SAR study, and biological evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors with reduced CYP3A4 inhibition.
    Hamaguchi W; Masuda N; Miyamoto S; Shiina Y; Kikuchi S; Mihara T; Moriguchi H; Fushiki H; Murakami Y; Amano Y; Honbou K; Hattori K
    Bioorg Med Chem; 2015 Jan; 23(2):297-313. PubMed ID: 25515954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
    Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
    Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study.
    Persson J; Szalisznyó K; Antoni G; Wall A; Fällmar D; Zora H; Bodén R
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):451-459. PubMed ID: 31119377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
    Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
    Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor.
    Takano A; Stenkrona P; Stepanov V; Amini N; Martinsson S; Tsai M; Goldsmith P; Xie J; Wu J; Uz T; Halldin C; Macek TA
    Neuroimage; 2016 Nov; 141():10-17. PubMed ID: 27423256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a highly specific
    Xiao Z; Wei H; Xu Y; Haider A; Wei J; Yuan S; Rong J; Zhao C; Li G; Zhang W; Chen H; Li Y; Zhang L; Sun J; Zhang S; Luo HB; Yan S; Cai Q; Hou L; Che C; Liang SH; Wang L
    Acta Pharm Sin B; 2022 Apr; 12(4):1963-1975. PubMed ID: 35847497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.
    Tóth M; Häggkvist J; Stepanov V; Takano A; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Gulyás B; Halldin C
    Mol Imaging Biol; 2015 Aug; 17(4):445-9. PubMed ID: 25622810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.